BRIEF-Pentixapharm Holding AG Says Co Discontinues Preclinical Activities To Focus On Clinical Programs

Oct 23 (Reuters) – Pentixapharm Holding AG: * PENTIXAPHARM HOLDING AG – DISCONTINUES PRECLINICAL ACTIVITIES TO FOCUS ON CLINICAL PROGRAMS * PENTIXAPHARM HOLDING AG: SHARPENED FOCUS INCLUDES AN ADJUSTMENT OF ORGANIZATIONAL STRUCTURE, ACCOMPANIED BY A TARGETED WORKFORCE REDUCTION OF APPROX 50 % * PENTIXAPHARM HOLDING AG – ADJUSTMENTS ARE EXPECTED TO LOWER ANNUAL OPERATING COSTS AND EXTEND COMPANY'S CASH RUNWAY THROUGH Q1 OF 2027 Source text: Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)